Release Date: 13/12/11 11:10 Summary: Update on Recapitalisation Process Price Sensitive: No Download Document 200.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%